Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 187

1.

Responsive brain stimulation in epilepsy.

Hartshorn A, Jobst B.

Ther Adv Chronic Dis. 2018 Jul;9(7):135-142. doi: 10.1177/2040622318774173. Epub 2018 May 7. Review.

2.

Carotid stenting with proximal cerebral protection in symptomatic low-grade vulnerable recurrent carotid stenosis.

de Haro J, Rodriguez-Padilla J, Bleda S, Cañibano C, Michel I, Acin F.

Ther Adv Chronic Dis. 2018 Jun;9(6):125-133. doi: 10.1177/2040622318765727. Epub 2018 Mar 27.

3.

Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept.

Rendina M, Castellaneta NM, Losurdo G, Castellaneta A, Cazzolla A, Chialà C, D'Errico F, Di Leo A.

Ther Adv Chronic Dis. 2018 Jun;9(6):121-123. doi: 10.1177/2040622318755651. Epub 2018 Feb 12. No abstract available.

4.

Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment.

Chan TC, Hawkes JE, Krueger JG.

Ther Adv Chronic Dis. 2018 May;9(5):111-119. doi: 10.1177/2040622318759282. Epub 2018 Mar 19.

5.

Time to reappraise the therapeutic place of celecoxib.

Beales ILP.

Ther Adv Chronic Dis. 2018 May;9(5):107-110. doi: 10.1177/2040622317749394. Epub 2018 Jan 3. No abstract available.

6.

Dealing with uncertainty in the treatment of Helicobacter pylori.

Calvet X.

Ther Adv Chronic Dis. 2018 Apr;9(4):93-102. doi: 10.1177/2040622318758240. Epub 2018 Feb 12. Review.

7.

New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.

Dubash S, McGonagle D, Marzo-Ortega H.

Ther Adv Chronic Dis. 2018 Mar;9(3):77-87. doi: 10.1177/2040622317743486. Epub 2017 Dec 14. Review.

8.

Acute severe ulcerative colitis: latest evidence and therapeutic implications.

Dulai PS, Jairath V.

Ther Adv Chronic Dis. 2018 Feb;9(2):65-72. doi: 10.1177/2040622317742095. Epub 2017 Nov 24. Review.

9.

Developments in rare bone diseases and mineral disorders.

Bacon S, Crowley R.

Ther Adv Chronic Dis. 2018 Jan;9(1):51-60. doi: 10.1177/2040622317739538. Epub 2017 Nov 24. Review.

10.

Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential.

Røder ME.

Ther Adv Chronic Dis. 2018 Jan;9(1):33-50. doi: 10.1177/2040622317735283. Epub 2017 Nov 9. Review.

11.

Management of functional dyspepsia: state of the art and emerging therapies.

Yamawaki H, Futagami S, Wakabayashi M, Sakasegawa N, Agawa S, Higuchi K, Kodaka Y, Iwakiri K.

Ther Adv Chronic Dis. 2018 Jan;9(1):23-32. doi: 10.1177/2040622317725479. Epub 2017 Aug 27. Review.

12.

Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.

Frieder J, Kivelevitch D, Menter A.

Ther Adv Chronic Dis. 2018 Jan;9(1):5-21. doi: 10.1177/2040622317738910. Epub 2017 Nov 16. Review.

13.

Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.

Hammersley D, Signy M.

Ther Adv Chronic Dis. 2017 Dec;8(12):165-176. doi: 10.1177/2040622317720106. Epub 2017 Jul 26. Review.

14.

Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy.

Barshop K, Staller K.

Ther Adv Chronic Dis. 2017 Nov;8(11):153-160. doi: 10.1177/2040622317714389. Epub 2017 Jun 21. Review.

15.

Haemorrhoids: an update on management.

Brown SR.

Ther Adv Chronic Dis. 2017 Oct;8(10):141-147. doi: 10.1177/2040622317713957. Epub 2017 Jun 21. Review.

16.

Strategies for dementia prevention: latest evidence and implications.

Rakesh G, Szabo ST, Alexopoulos GS, Zannas AS.

Ther Adv Chronic Dis. 2017 Aug;8(8-9):121-136. doi: 10.1177/2040622317712442. Epub 2017 Jun 27. Review.

17.

Evaluation of medication adherence in chronic disease at a federally qualified health center.

Oung AB, Kosirog E, Chavez B, Brunner J, Saseen JJ.

Ther Adv Chronic Dis. 2017 Aug;8(8-9):113-120. doi: 10.1177/2040622317714966. Epub 2017 Jun 21.

18.

Achalasia: current therapeutic options.

Arora Z, Thota PN, Sanaka MR.

Ther Adv Chronic Dis. 2017 Jun;8(6-7):101-108. doi: 10.1177/2040622317710010. Epub 2017 Jun 23. Review.

19.

Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis.

Sambataro G, Sambataro D, Polosa R.

Ther Adv Chronic Dis. 2017 Jun;8(6-7):97-99. doi: 10.1177/2040622317702363. Epub 2017 May 10. No abstract available.

20.

Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy.

Babu KS, Morjaria JB.

Ther Adv Chronic Dis. 2017 Apr;8(4-5):81-91. doi: 10.1177/2040622317700822. Epub 2017 Mar 24. Review.

Supplemental Content

Loading ...
Support Center